Literature DB >> 21184108

Minimally invasive colon resection is associated with a persistent increase in plasma PlGF levels following cancer resection.

H M C Shantha Kumara1, Jenny C Cabot, Xiaohong Yan, Sonali A C Herath, Martin Luchtefeld, Matthew F Kalady, Daniel L Feingold, Raymond Baxter, Richard L Whelan.   

Abstract

BACKGROUND: Minimally invasive colorectal resection (MICR) is associated with persistently elevated plasma VEGF levels that may stimulate angiogenesis in residual tumor foci. Placenta growth factor (PlGF) stimulates neovascularization in tumors by modulating VEGF's effects. This study's purpose was to determine the impact of MICR on blood PlGF levels in cancer patients (Study A) and to compare PreOp levels in patients with cancer and benign (BEN) disease (Study B).
METHODS: Blood samples were collected preoperatively, on postoperative day (POD) 1, POD 3, and at various time points 2-4 weeks after surgery. Samples from 7-day periods after POD 6 were bundled to allow analysis. Plasma PlGF levels were determined via ELISA, results reported as mean±SD, and data analyzed via t test. Significance was set at p<0.008 after Bonferroni correction.
RESULTS: Study A: 76 colorectal cancer (CRC) patients had MICR (laparoscopic, 59%; hand-assisted, 41%). The mean length of stay was 5.8±2.1 days. The mean PreOp PlGF level was 15.4±4.3 pg/ml. Significantly increased levels were noted on POD 1 (25.8±7.7 pg/ml, p<0.001), POD 3 (22.9±6.7, p<0.001), POD 7-13 (19.2±5.1, p<0.001), and POD 14-20 (19.5±6.7, p<0.002). The mean POD 21-27 level was not significantly different from baseline. Study B included 126 CRC and 111 BEN patients. PreOp levels were higher in the CRC patients (15.6±5.3 pg/ml) than in the BEN group (13.5±5.5 pg/ml, p=0.001).
CONCLUSIONS: PlGF levels are elevated for 3 weeks after MICR and PreOp plasma levels are higher in CRC patients than in BEN disease patients. The cause of the postoperative increase is unclear. The persistently higher blood levels of PlGF and VEGF after MICR may stimulate angiogenesis in residual tumor foci. Further studies regarding late blood protein alterations after surgery appear to be indicated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21184108     DOI: 10.1007/s00464-010-1514-z

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  32 in total

1.  Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

Authors:  P Carmeliet; L Moons; A Luttun; V Vincenti; V Compernolle; M De Mol; Y Wu; F Bono; L Devy; H Beck; D Scholz; T Acker; T DiPalma; M Dewerchin; A Noel; I Stalmans; A Barra; S Blacher; T VandenDriessche; A Ponten; U Eriksson; K H Plate; J M Foidart; W Schaper; D S Charnock-Jones; D J Hicklin; J M Herbert; D Collen; M G Persico
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

2.  Cellular and humoral inflammatory response after laparoscopic and conventional colorectal resections.

Authors:  J Ordemann; C A Jacobi; W Schwenk; R Stösslein; J M Müller
Journal:  Surg Endosc       Date:  2001-04-03       Impact factor: 4.584

3.  Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma.

Authors:  K Maeda; S M Kang; N Onoda; M Ogawa; Y Kato; T Sawada; K H Chung
Journal:  Cancer       Date:  1999-08-15       Impact factor: 6.860

4.  Placental growth factor is a survival factor for tumor endothelial cells and macrophages.

Authors:  Avner Adini; Tad Kornaga; Farshid Firoozbakht; Laura E Benjamin
Journal:  Cancer Res       Date:  2002-05-15       Impact factor: 12.701

5.  Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor.

Authors:  W L Monsky; D Fukumura; T Gohongi; M Ancukiewcz; H A Weich; V P Torchilin; F Yuan; R K Jain
Journal:  Cancer Res       Date:  1999-08-15       Impact factor: 12.701

6.  Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels.

Authors:  Christian Fischer; Bart Jonckx; Massimiliano Mazzone; Serena Zacchigna; Sonja Loges; Lucia Pattarini; Emmanuel Chorianopoulos; Laurens Liesenborghs; Marta Koch; Maria De Mol; Monica Autiero; Sabine Wyns; Stephane Plaisance; Lieve Moons; Nico van Rooijen; Mauro Giacca; Jean-Marie Stassen; Mieke Dewerchin; Desire Collen; Peter Carmeliet
Journal:  Cell       Date:  2007-11-02       Impact factor: 41.582

7.  Persistent elevation of plasma vascular endothelial growth factor levels during the first month after minimally invasive colorectal resection.

Authors:  A Belizon; E Balik; P Horst; D Feingold; T Arnell; T Azarani; V Cekic; R Skitt; S Kumara; R L Whelan
Journal:  Surg Endosc       Date:  2008-01-18       Impact factor: 4.584

8.  Differential expression of vascular endothelial growth factor-A isoforms at different stages of melanoma progression.

Authors:  David H Gorski; Alejandro D Leal; James S Goydos
Journal:  J Am Coll Surg       Date:  2003-09       Impact factor: 6.113

9.  Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.

Authors:  Y Takahashi; Y Kitadai; C D Bucana; K R Cleary; L M Ellis
Journal:  Cancer Res       Date:  1995-09-15       Impact factor: 12.701

10.  Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis.

Authors:  A Takahashi; H Sasaki; S J Kim; K Tobisu; T Kakizoe; T Tsukamoto; Y Kumamoto; T Sugimura; M Terada
Journal:  Cancer Res       Date:  1994-08-01       Impact factor: 12.701

View more
  12 in total

1.  Plasma soluble vascular adhesion molecule-1 levels are persistently elevated during the first month after colorectal cancer resection.

Authors:  H M C Shantha Kumara; Samer T Tohme; Sonali A C Herath; Xiaohong Yan; Anthony J Senagore; Abu Nasar; Matthew F Kalady; Raymond Baxter; Richard L Whelan
Journal:  Surg Endosc       Date:  2012-01-05       Impact factor: 4.584

2.  Plasma interleukin-8 levels are persistently elevated for 1 month after minimally invasive colorectal resection for colorectal cancer.

Authors:  H M C Shantha Kumara; Elli Sutton; Geoffrey A Bellini; Xiaohong Yan; Vesna Cekic; Nipa Dilip Gandhi; Richard L Whelan
Journal:  Mol Clin Oncol       Date:  2017-12-18

3.  Silencing of VEGF inhibits human osteosarcoma angiogenesis and promotes cell apoptosis via VEGF/PI3K/AKT signaling pathway.

Authors:  Ningning Peng; Shuming Gao; Xu Guo; Guangya Wang; Cai Cheng; Min Li; Kehun Liu
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

4.  Plasma from the second and third weeks after open colorectal resection for cancer stimulates in vitro endothelial cell growth, migration, and invasion.

Authors:  H M C Shantha Kumara; Daniel Kirchoff; Samer Naffouje; Michael Grieco; Sonali A C Herath; Nadav Dujovny; Matthew F Kalady; Neil Hyman; Linda Njoh; Richard L Whelan
Journal:  Surg Endosc       Date:  2011-11-15       Impact factor: 4.584

5.  Plasma levels of angiopoietin-like protein 4 (ANGPTL4) are significantly lower preoperatively in colorectal cancer patients than in cancer-free patients and are further decreased during the first month after minimally invasive colorectal resection.

Authors:  H M C Shantha Kumara; Daniel Kirchoff; Sajith A Herath; Joon Ho Jang; Xiaohong Yan; Michael Grieco; Vesna Cekic; Richard L Whelan
Journal:  Surg Endosc       Date:  2012-05-02       Impact factor: 4.584

6.  Plasma monocyte chemotactic protein-1 remains elevated after minimally invasive colorectal cancer resection.

Authors:  H M C Shantha Kumara; Elizabeth A Myers; Sonali Ac Herath; Joon Ho Jang; Linda Njoh; Xiaohong Yan; Daniel Kirchoff; Vesna Cekic; Martin Luchtefeld; Richard L Whelan
Journal:  World J Gastrointest Oncol       Date:  2014-10-15

7.  Plasma chitinase 3-like 1 is persistently elevated during first month after minimally invasive colorectal cancer resection.

Authors:  H M C Shantha Kumara; David Gaita; Hiromichi Miyagaki; Xiaohong Yan; Sonali Ac Hearth; Linda Njoh; Vesna Cekic; Richard L Whelan
Journal:  World J Gastrointest Oncol       Date:  2016-08-15

8.  Minimally invasive colorectal resection is associated with significantly elevated levels of plasma matrix metalloproteinase 3 (MMP-3) during the first month after surgery which may promote the growth of residual metastases.

Authors:  H M C Shantha Kumara; David J Gaita; Hiromichi Miyagaki; Xiaohong Yan; Sonali A C Herath; Vesna Cekic; Richard L Whelan
Journal:  Surg Endosc       Date:  2014-06-18       Impact factor: 4.584

Review 9.  Designing a broad-spectrum integrative approach for cancer prevention and treatment.

Authors:  Keith I Block; Charlotte Gyllenhaal; Leroy Lowe; Amedeo Amedei; A R M Ruhul Amin; Amr Amin; Katia Aquilano; Jack Arbiser; Alexandra Arreola; Alla Arzumanyan; S Salman Ashraf; Asfar S Azmi; Fabian Benencia; Dipita Bhakta; Alan Bilsland; Anupam Bishayee; Stacy W Blain; Penny B Block; Chandra S Boosani; Thomas E Carey; Amancio Carnero; Marianeve Carotenuto; Stephanie C Casey; Mrinmay Chakrabarti; Rupesh Chaturvedi; Georgia Zhuo Chen; Helen Chen; Sophie Chen; Yi Charlie Chen; Beom K Choi; Maria Rosa Ciriolo; Helen M Coley; Andrew R Collins; Marisa Connell; Sarah Crawford; Colleen S Curran; Charlotta Dabrosin; Giovanna Damia; Santanu Dasgupta; Ralph J DeBerardinis; William K Decker; Punita Dhawan; Anna Mae E Diehl; Jin-Tang Dong; Q Ping Dou; Janice E Drew; Eyad Elkord; Bassel El-Rayes; Mark A Feitelson; Dean W Felsher; Lynnette R Ferguson; Carmela Fimognari; Gary L Firestone; Christian Frezza; Hiromasa Fujii; Mark M Fuster; Daniele Generali; Alexandros G Georgakilas; Frank Gieseler; Michael Gilbertson; Michelle F Green; Brendan Grue; Gunjan Guha; Dorota Halicka; William G Helferich; Petr Heneberg; Patricia Hentosh; Matthew D Hirschey; Lorne J Hofseth; Randall F Holcombe; Kanya Honoki; Hsue-Yin Hsu; Gloria S Huang; Lasse D Jensen; Wen G Jiang; Lee W Jones; Phillip A Karpowicz; W Nicol Keith; Sid P Kerkar; Gazala N Khan; Mahin Khatami; Young H Ko; Omer Kucuk; Rob J Kulathinal; Nagi B Kumar; Byoung S Kwon; Anne Le; Michael A Lea; Ho-Young Lee; Terry Lichtor; Liang-Tzung Lin; Jason W Locasale; Bal L Lokeshwar; Valter D Longo; Costas A Lyssiotis; Karen L MacKenzie; Meenakshi Malhotra; Maria Marino; Maria L Martinez-Chantar; Ander Matheu; Christopher Maxwell; Eoin McDonnell; Alan K Meeker; Mahya Mehrmohamadi; Kapil Mehta; Gregory A Michelotti; Ramzi M Mohammad; Sulma I Mohammed; D James Morre; Vinayak Muralidhar; Irfana Muqbil; Michael P Murphy; Ganji Purnachandra Nagaraju; Rita Nahta; Elena Niccolai; Somaira Nowsheen; Carolina Panis; Francesco Pantano; Virginia R Parslow; Graham Pawelec; Peter L Pedersen; Brad Poore; Deepak Poudyal; Satya Prakash; Mark Prince; Lizzia Raffaghello; Jeffrey C Rathmell; W Kimryn Rathmell; Swapan K Ray; Jörg Reichrath; Sarallah Rezazadeh; Domenico Ribatti; Luigi Ricciardiello; R Brooks Robey; Francis Rodier; H P Vasantha Rupasinghe; Gian Luigi Russo; Elizabeth P Ryan; Abbas K Samadi; Isidro Sanchez-Garcia; Andrew J Sanders; Daniele Santini; Malancha Sarkar; Tetsuro Sasada; Neeraj K Saxena; Rodney E Shackelford; H M C Shantha Kumara; Dipali Sharma; Dong M Shin; David Sidransky; Markus David Siegelin; Emanuela Signori; Neetu Singh; Sharanya Sivanand; Daniel Sliva; Carl Smythe; Carmela Spagnuolo; Diana M Stafforini; John Stagg; Pochi R Subbarayan; Tabetha Sundin; Wamidh H Talib; Sarah K Thompson; Phuoc T Tran; Hendrik Ungefroren; Matthew G Vander Heiden; Vasundara Venkateswaran; Dass S Vinay; Panagiotis J Vlachostergios; Zongwei Wang; Kathryn E Wellen; Richard L Whelan; Eddy S Yang; Huanjie Yang; Xujuan Yang; Paul Yaswen; Clement Yedjou; Xin Yin; Jiyue Zhu; Massimo Zollo
Journal:  Semin Cancer Biol       Date:  2015-12       Impact factor: 15.707

10.  Plasma levels of the proangiogenic protein CXCL16 remains elevated for 1 month after minimally invasive colorectal cancer resection.

Authors:  H M C Shantha Kumara; Erica Pettke; Abhinit Shah; Xiaohong Yan; Vesna Cekic; Melissa Alvarez Downing; Nipa Dilip Gandhi; Richard L Whelan
Journal:  World J Surg Oncol       Date:  2018-07-07       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.